Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain

NCT02228928 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Nerve Injury
Postherpetic Neuralgia

Interventions

DRUG: CAPNP, 50 ug/cm2 capsaicin patch
DRUG: CAPNP, 100 ug/cm2 capsaicin patch
DRUG: 0.075% capsaicin cream
OTHER: Placebo patch

Sponsor

Samyang Biopharmaceuticals Corporation